KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for Nu Skin Enterprises (NUS) over the last 5 years, with Q1 2025 value amounting to $25.1 million.

  • Nu Skin Enterprises' Asset Writedowns and Impairment rose 115381.93% to $25.1 million in Q1 2025 from the same period last year, while for Sep 2025 it was $58.8 million, marking a year-over-year decrease of 6124.72%. This contributed to the annual value of $181.1 million for FY2024, which is 10550.8% up from last year.
  • As of Q1 2025, Nu Skin Enterprises' Asset Writedowns and Impairment stood at $25.1 million, which was up 115381.93% from $33.7 million recorded in Q4 2024.
  • In the past 5 years, Nu Skin Enterprises' Asset Writedowns and Impairment registered a high of $145.3 million during Q2 2024, and its lowest value of $2.0 million during Q1 2024.
  • Over the past 5 years, Nu Skin Enterprises' median Asset Writedowns and Impairment value was $18.5 million (recorded in 2023), while the average stood at $33.2 million.
  • As far as peak fluctuations go, Nu Skin Enterprises' Asset Writedowns and Impairment tumbled by 8299.26% in 2022, and later skyrocketed by 115381.93% in 2025.
  • Quarter analysis of 5 years shows Nu Skin Enterprises' Asset Writedowns and Impairment stood at $31.9 million in 2021, then tumbled by 82.99% to $5.4 million in 2022, then fell by 17.66% to $4.5 million in 2023, then soared by 655.02% to $33.7 million in 2024, then decreased by 25.52% to $25.1 million in 2025.
  • Its Asset Writedowns and Impairment stands at $25.1 million for Q1 2025, versus $33.7 million for Q4 2024 and $145.3 million for Q2 2024.